19 October 2026
strategyland.uk
Tate & Lyle PLC (TATE)
Rank #254 of 280 - Consumer Non-Cyclicals - UK Equities
Tate & Lyle PLC
Factor Analysis Summary
Editorial assessment generated from Tate & Lyle PLC's live factor scores and sector positioning.
Based on Strategyland's proprietary 7-factor analysis, Tate & Lyle PLC (TATE.L) currently holds an overall rank of #254 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.
Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit, and technical (RSI 46.7), where it demonstrates positive technical momentum with price action supporting a constructive trend.
Areas requiring attention include profitability (ROE 5.6%, net margin 4.5%), where compressed margins and weak returns on equity weigh on the earnings profile, as well as solvency (debt/equity 0.8), where higher debt levels or weaker coverage ratios raise solvency concerns.
Within the Consumer Non-Cyclicals sector, Tate & Lyle PLC sits at composite rank #254, trailing the Consumer Non-Cyclicals peer average (rank 53). It ranks behind all 6 tracked Consumer Non-Cyclicals peers in our model.
Despite its mid-table composite rank of #254, Tate & Lyle PLC shows selective strength — notably in liquidity and technical — suggesting a stock with identifiable merits alongside clear areas for improvement.
Strongest Factors
- Liquidity — Rank 30/280 (top quartile)
- Technical — Rank 30/280 (top quartile)
- Market Trading — Rank 140/280 (middle of the pack)
Weakest Factors
- Profitability — Rank 251/280 (below average)
- Solvency — Rank 213/280 (below average)
Score Analysis
Tate & Lyle PLC is ranked #254 out of 280 UK stocks. Lower factor scores indicate better performance in that category.
Factor Breakdown
1. Liquidity
Score: 30/280How liquid is TATE and can it meet its short-term obligations?
Key Liquidity Metrics
Overall Liquidity Rank
2. Valuation
Score: 150/280Is TATE undervalued compared to its peers and fair value metrics?
Key Valuation Metrics
Dividend
TATE pays a dividend yield of 5.52%.
Dividend Per Share Forecast
3. Profitability
Score: 251/280How profitable is TATE relative to its peers?
EPS Growth
4. Solvency
Score: 213/280How strong is TATE's balance sheet and financial position?
Key Solvency Metrics
Altman Z-Score
5. Asset Efficiency
Score: 160/280How efficiently does TATE deploy its assets and intellectual capital?
Overall Asset Efficiency Rank
6. Market Trading
Score: 140/280How liquid and actively traded is TATE?
Trading Volume
7. Technical
Score: 30/280What do the technical indicators say about TATE?
RSI (14 Day)
Moving Averages
Risk Metrics
Peer Comparison
How does TATE compare to other Consumer Non-Cyclicals stocks?
Overall Rank Comparison
Factor Score Comparison
Similar Stocks
Other top-ranked stocks in the Consumer Non-Cyclicals sector
LiveCatch Healthcare Events Before the Market Moves
SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.
Methodology Note
The analysis presented for Tate & Lyle PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.
Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.
This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.
© 2026 Strategyland by Khurram. All rights reserved.
